Physician profile
Doroty Devalon
NPI 1629544234
$2,606.11
in general payments reported to CMS, 2019-2025
22 companies · $1,797 in 2025
The $1,797 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $148 · 2023: $110 · 2024: $551 · 2025: $1,797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,187 · Travel and Lodging: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,186.71 |
| Travel and Lodging | $271.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $700.49 | 2025 | Proclaim |
| Abbvie INC. | $361.79 | 2024-2025 | |
| Ibsa Pharma INC. | $295.17 | 2024-2025 | Tirosint, Licart, Flector |
| Collegium Pharmaceutical, INC. | $270.83 | 2021-2025 | Belbuca, Nucynta, Xtampza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $214.68 | 2024-2025 | Relistor |
| Spr Therapeutics, INC | $90.91 | 2024-2025 | Sprint Pns System |
| Pfizer INC. | $89.73 | 2024-2025 | |
| Medtronic, INC. | $82.17 | 2024 | Intellis Adaptivestim |
| Vertex Pharmaceuticals Incorporated | $76.39 | 2025 | |
| Saluda Medical Americas, INC. | $67.55 | 2024-2025 | Evoke |
| Boston Scientific Corporation | $59.95 | 2023 | Wavewriter Alpha Prime 16 |
| Lilly USA, LLC | $53.66 | 2021-2024 | Emgality, Reyvow |
| Axsome Therapeutics, INC. | $39.68 | 2025 | Symbravo |
| Spinal Simplicity, LLC | $37.84 | 2024-2025 | Ha Minuteman G3-R |
| Globus Medical, INC. | $33.18 | 2025 | Senza |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $32.88 | 2023 | Prevena Restor Arthroform |
| Horizon Therapeutics Plc | $18.10 | 2021 | |
| Depuy Synthes Sales INC. | $17.09 | 2023 | Monovisc |
| Pacira Pharmaceuticals Incorporated | $16.98 | 2025 | Zilretta, Iovera |
| Biodelivery Sciences International, INC. | $16.76 | 2021 | |
| Currax Pharmaceuticals LLC | $16.27 | 2021 | |
| Forte Bio-Pharma LLC | $14.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doroty Devalon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.